Neither inflammation, as evidenced by CRP-levels, nor overall stroke risk (CHA2DS2 VASc score), biomarkers of cardiovascular risk (NT-proBNP, CK) and echocardiographic parameters of atrial remodeling (septal PA TDI, LAVI/a) correlated with FAP concentration in our cohorts. The gene discussed is CRP; the disease is stroke disorder.